Glucagen, Hypokit

Glucagen, Hypokit is a prescription medication that contains the peptide hormone glucagon as its active ingredient. The product is supplied in an injectable form, though specific strength and dosage form details are not publicly disclosed. It is marketed in the European Union and is classified under the therapeutic class for hypoglycemia treatment. Glucagon works by stimulating hepatic glycogenolysis and gluconeogenesis to raise blood glucose levels.

Glucagen, Hypokit is indicated for emergency treatment of severe hypoglycemia and certain drug overdoses. It is administered when rapid elevation of blood glucose is required.

- Management of severe hypoglycemia in diabetic patients when oral glucose is ineffective or unavailable - Treatment of hypoglycemia unresponsive to glucagon-like emergency kits - Reversal of beta‑blocker overdose when conventional therapies are insufficient - Adjunct therapy in cases of insulin overdose - Use in emergency settings where rapid glucose restoration is critical

Glucagen, Hypokit may cause a range of side effects, most of which are transient and related to its mechanism of action.

Common: - Nausea or vomiting - Flushing or warmth sensation - Headache - Dizziness - Local pain or irritation at the injection site - Transient hyperglycemia

Serious: - Allergic reactions including rash, itching, or swelling - Severe hyperglycemia requiring medical attention - Cardiovascular events such as tachycardia or arrhythmia - Pancreatitis (rare) - Hypotension (rare) - Injection site necrosis (very rare)

Before using Glucagen, Hypokit, certain precautions should be considered to ensure safe administration.

- Verify the diagnosis of severe hypoglycemia before injection - Use only under medical supervision or as directed in emergency protocols - Assess for known hypersensitivity to glucagon or any excipients - Caution in patients with pheochromocytoma or insulinoma due to potential exaggerated glucose response - Monitor blood glucose levels after administration to avoid rebound hyperglycemia - Store the product according to manufacturer instructions to maintain potency - Do not reuse needles or syringes to prevent infection

Glucagen, Hypokit can interact with other medications, influencing its effectiveness or safety profile.

Avoid: - Concurrent use of beta‑blockers that may mask typical glucagon side effects such as tachycardia - High-dose insulin therapy without appropriate monitoring, which may exacerbate hypoglycemia cycles

Use with caution: - Oral hypoglycemic agents (e.g., sulfonylureas) that may increase risk of recurrent hypoglycemia - Medications that affect hepatic glycogen stores, such as corticosteroids - Drugs that alter cardiovascular response, including calcium channel blockers - Anticholinergic agents that may affect gastrointestinal motility and glucagon absorption